EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Coin stacks

AstraZeneca bets big on US, pledges to invest $3.5bn

Discover how AZ’s capital investment is set to expand its US research and manufacturing capabilities by the end of 2026.
Red arrow tracking bar chart that is ascending in height

BMS, Gilead and Sanofi lead Q3 2024 market cap growth

The third quarter of 2024 brought a mix of gains and modest declines for the pharmaceutical industry’s top players, according to GlobalData.

FDA nod for Johnson & Johnson’s atrial fibrillation device

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.
white house on blue background

What does Trump's win mean for pharma?

With Donald Trump securing a second presidential term, what issues should be top of mind for the pharmaceutical sector in the US? 

AZ's new obesity pill shows promise, enters phase II

AstraZeneca’s new weight-loss pill, licensed from China’s Eccogene last year, has shown initial promise in early-stage trials.
The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: October 2024

Catch up on all the biggest news to hit the pharmaceutical industry last month, spanning from new acquisitions, approvals, insights on the NHS and more.
5 stars

Boehringer, Amgen and Novartis rank top for cardiovascular patient groups

Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.

Sustainable pharma packaging takes a big step forward

UPM Biochemicals, Selenis and Bormioli Pharma have introduced the pharmaceutical industry’s first bottle made with wood-based PET.
We’ve noticed you’re accessing
from North/South America.